Organisation
- Acronym
- FRRB
- Role
- Partner
- Country
- IT
- Address
- Palazzo Lombardia, Piazza Città di Lombardia,1 20124
- Website
- https://frrb.it/
Partner
IT
IT
Fondazione Regionale per la Ricerca Biomedica
FRRB
Programme phases
2
TRANSCAN-3
2021–2027
View phase
TRANSCAN-4
2026–2031
View phase
Funding participation
Joint calls funded by this organisation.
Funded projects
Projects linked to this funding organisation.
DICE
Epigenomic regulation of cancer immunity by dietary intervention
JTC 2023
View project
HYDRA
Charting the epigenomic trajectory of progression towards metastatic colorectal cancer
JTC 2023
View project
iCC-Strat
Risk stratification and subtyping of intrahepatic cholangiocarcinoma for early detection of recurrence and response to immuno-therapy
JTC 2022
View project
iMMunocell
Single-cell immunophenotypic and transcriptomic profiling for minimally-invasive detection of early multiple myeloma
JTC 2016
View project
LipidMac
Exploiting lipid-laden macrophages to overcome resistance to cancer immunotherapy
JTC 2021
View project
LUNGOIDS
Subtype-specific Lung Cancer Organoids based on artificial ECM for Precision Oncology: Closing the Gap Between Preclinical Models and Patient Care
JTC 2024
View project
PIXEL
Profiling and functional analysis of the Immune environment of eXtramedullary leukemia rELapses
JTC 2021
View project
Quant-ALL
Automated, absolute quantification of MRD in ALL patients by droplet microfluidics, single DNA copy barcoding and IG/TR amplicon NGS
JTC 2017
View project
SCRAtCH
Microbiota-based screening of anal cancer in HIV-infected individuals
JTC 2016
View project
T-Plex EAC
T-Plex-Capture: Isolation of neoantigen-specific CD8+ T cell receptors for patient-specific immunotherapy in esophageal adenocarcinoma (EAC)
JTC 2022
View project
TITAN
Novel Cancer Therapy: Inducing Double-strand DNA Breaks to Foster Tumor Cell Death, Antigenicity and Immunotherapy Response in New Personalized Models
JTC 2024
View project
TRANSCALL-2
Integration of genetic biomarkers and early Minimal Residual Disease to improve risk stratification and cure in childhood Acute Lymphoblastic Leukemia
JTC 2016
View project